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Background: Avian influenza virus (AIV) induced proinflammatory cytokine expression is believed to contribute to
the disease pathogenesis following infection of poultry. However, there is limited information on the avian immune
response to infection with low pathogenic avian influenza virus (LPAIV).
Methods: To gain a better understanding of the early viral-host interactions of LPAIV in chickens, primary chicken
embryo hepatocytes (CEH) were infected with four different LPAIVs of U.S. origin. Kinetics of virus replication, transcription
factor (c-Jun, p50 and IRF-3) activation and immune response gene (IL-6, IL-1beta, IFN-alpha and Mx) expression were
studied at four different time points (6, 12, 24 and 48 hours) post infection and compared to non-infected controls.
Results: CEH can support growth of the tested LPAIVs when with trypsin supplementation. All four immune response
genes tested were upregulated following infection as were transcription factors c-Jun, p50 and IRF-3. Amplification of
these genes was dependant on virus replication (e.g. inclusion of trypsin), such that immune response genes and
transcription factors were upregulated as viral titers increased.
Conclusion: The results of these studies demonstrate the requirement of virus replication for innate immune regulation
and broaden our understanding of transcription factor responses related to LPAIV infection in chickens.
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Avian influenza (AI) infection in poultry can result in
high morbidity and mortality, and negatively affect inter-
national trade [1]. AIV can be categorized into 16 differ-
ent hemagglutinin (HA) subtypes (H1–H16) and 9
different neuraminidases (N1–N9) subtypes which can
occur in many combinations [2]. During the past decade,
low pathogenic (LP) AIV has caused considerable eco-
nomic loss due to decreased production, increased mor-
bidity and increase the cost of vaccination in poultry
industry [3]. LPAI viruses have the potential to evolve
into highly pathogenic (HP) AIV and this has been docu-
mented in many poultry outbreaks. However, only the* Correspondence: darrell.kapczynski@ars.usda.gov
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reproduction in any medium, provided the orH5 and H7 subtypes, have been associated with HPAI
mutation [4,5]. This has led to a new proposed definition
of avian influenza to extend all infections caused by H5
and H7 viruses regardless of their virulence as notifiable
avian influenza (NAI) [6]. The H9N2 subtype was first
reported to infect turkeys in the United States in 1966
and has seriously affected the poultry industry of the
Asia and Middle East since the mid-1990s [7-9]. This
subtype is considered one of the most likely candidates
to cause a new influenza pandemic in humans [10]. In
1999 and 2003, the reports of H9N2 AIV infections of
humans in Hong Kong dramatically attracted the atten-
tion of the scientific community [11,12].
The innate immune system response is the first line of
defense and limits early virus replication [13]. Cytokines are
important immune mediators of innate and acquired im-
munity responsible for initiating, amplifying and regulatingtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.








































Figure 1 Kinetics of CEH infection by H5N9, H5N3, H7N2 and
H9N2 viruses. Cells were infected at MOI of 1 and supplemented
with1μg/ml trypsin or without trypsin in the medium. The viral titers
in supernatants collected at 6, 12, 24 and 48 hpi were determined as
log10EID50/ml. The patterns bars represent the viral titers achieved
without the use of supplemental trypsin. The gray bar stacked on
top represents the increase in the viral titers with the addition of
supplemental trypsin. Error bars show standard deviation of the
mean, n = 3. *Indicates the difference (P < 0.05) between the
supplemented with and without trypsin group.
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Knowledge of the innate immune recognition of AIV is
crucial to understanding the viral pathogenesis in birds.
Recognition of pathogen-associated molecular patterns
(PAMPs) by host pattern recognition receptors (PRRs) rep-
resents a critical step in innate immune responses [16].
Proper communication between host cells and pathogen
via PAMPs and PRRs initiates signal transduction pathways
which in turn induces the expression of cytokines aimed at
controlling pathogens [17].
Recognition of the virus through PRRs, such as retinoic-
acid inducible gene I (RIG-I), melanoma differentiation-
associated gene 5 (MDA-5) and toll-like receptors (TLRs)
induces activation and translocation of transcription factors
to nucleus, including activator protein-1 (AP-1), interferon
regulatory (IRF) factor 3 (IRF-3) and nuclear factor-kappa β
(NF-κβ), which collaborate to induce transcription of vari-
ous cytokines such as alpha/beta interferon, leading to
clearance of the infectious pathogens [18]. Understanding
the mechanisms that regulate innate immune responses to
AIV is of key importance to develop novel virus-based
therapeutic strategies. In mammals, studies have been car-
ried out to examine the transcription factors signaling path-
ways after infection with influenza virus, however, in
chicken very little is known [19]. Although no commercial
kit exists to examine chicken cellular transcription factors,
previous reports have confirmed the cross-reactivity be-
tween birds and mammals in c-Jun, IRF-3 and p50 [20-24].
Lesions and viral antigen distribution are frequently ob-
served in chicken liver infected with AIV [25-27]. Primary
chicken embryo hepatocytes (CEHs) have been used for
virus propagation, detection, and subsequent vaccine pro-
duction [28-30]. Here we used primary CEHs which are
readily used to study AIV infections because of their high
susceptibility, thus are suitable to detect changes in gene
expression early in the course of infection under controlled
conditions. In this study, we compared viral replication,
virus-induced cytokine gene expression and activation of
cellular transcription factors associated with low pathogenic
H5N3, H5N9, H7N2 and H9N2 viruses infection of CEH.
The objective was to understand the early immune and cel-
lular responses to broaden our understanding of the mo-
lecular mechanisms related to LPAIV infection in chicken.
Results
Growth kinetics of viruses on CEH
To investigate the replication of different virus strains,
CEHs were infected with H5N9, H5N3, H7N2 and
H9N2 viruses at MOI of 1 and the viral titers in the su-
pernatants were determined as log10EID50/ml. Com-
parison of the growth characteristics of H5N9, H5N3,
H7N2 and H9N2 viruses in CEHs with or without tryp-
sin supplementation in the medium after infection are
shown in Figure 1. CEH cannot efficient support growthof the above viruses without supplemental trypsin in the
medium, presumably because CEH cannot produce
trypsin-like protease. But after with1 μg/ml trypsin sup-
plementation in the medium after infection, viral titers
increasing until 24 hpi, especially H7N2 virus has a sig-
nificant increase. The viral titers for H5N9, H5N3,
H7N2 and H9N2 at 24 hpi were 6.8, 6.8, 8.6, and 6.4
log10 EID50 per ml, respectively.
Pro-inflammatory IL-6/IL-1β expression following virus
growth on CEH
The influence of LPAIV on pro-inflammatory IL-6/IL-1β cy-
tokines expression in CEH (6, 12, 24 and 48 hpi) is shown
in Figure 2. The expression of IL-6 was similar in CEH with
trypsin supplementation after infection at the early stage of
viral infection, with a low expression level at 6 hpi and then
a slight increase at 12 hpi. However, IL-6 was significantly
upregulated at 24 and 48 hpi. H7N2 virus demonstrated the
highest expression level of IL-6 expression at 7.9-fold in-
crease compared to sham-infected cells at 48 hpi.
IL-1β expression was similar in CEH with trypsin sup-
plementation with a peak at 24 hpi and decreased at 48
hpi. H7N2 also demonstrated the highest level of expres-
sion (8.8-fold) at 24 hpi. Interestingly, the IL-6 and IL-1β
expression in CEH without trypsin after infection were far
lower compared to expression observed with trypsin.
Interferon-α and Myxovirus (Mx) expression following
virus growth on CEH
The induction of IFN-α and Mx expression in CEH (6,
12, 24 and 48 hpi) following LPAIV infection is shown
in Figure 3. The results show that IFN-α and Mx




























































Figure 2 Pro-inflammatory IL-6/IL-1β mRNA expression of CEH infection by H5N9, H5N3, H7N2 and H9N2 viruses. Cells were infected for
different time periods with LPAIV at MOI of 1 and supplemented with 1 μg/ml trypsin or without trypsin in the medium. Total RNA was isolated
and quantitated using QRRT-PCR. The horizontal axis represents virus. The vertical axis represents the fold change. Error bars represent standard
deviation across each condition performed in triplicate.
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Figure 3 Interferon-α/Mx mRNA expression of CEH infection by H5N9, H5N3, H7N2 and H9N2 viruses. Cells were infected for different
time periods with LPAIVs at MOI of 1 and supplemented with 1 μg/ml trypsin or without trypsin in the medium. Total RNA was isolated and
quantitated using QRRT-PCR. The horizontal axis represents virus. The vertical axis represents the fold change. Error bars represent standard
deviation across each condition performed in triplicate.
Jiang et al. Virology Journal 2013, 10:342 Page 3 of 8
http://www.virologyj.com/content/10/1/342
Jiang et al. Virology Journal 2013, 10:342 Page 4 of 8
http://www.virologyj.com/content/10/1/342expression pattern in the CEH with trypsin after infec-
tion are similar, with isolates inducing upregulated ex-
pression throughout the experiment. A significant
increase was observed when trypsin was added compare
to without trypsin. The H7N2 virus was observed to in-
duce much higher IFN-α and Mx expression on CEH
with trypsin than other viruses.
Activation of c-Jun, p50 and IRF-3 by LPAIVs
Infection of the CEH with LPAIV induced an increase in
DNA-binding transcription factors, c-Jun, p50 and IRF-
3, most notably with trypsin supplementation (Figure 4).
The activation patterns of c-Jun and p50 were similar in
CEH with a peak at 24 hpi and decreased levels at 48
hpi. Likewise, LPAIV induced an increase in IRF-3 with
all isolates upregulating expression throughout the ex-
periment. The H7N2 virus induced much higher in-
crease in c-Jun, p50 and IRF-3 on CEH than the other















































































Figure 4 C-Jun, p50 and IRF-3 activity in CEH in response to LPAIVs. C
and supplemented with 1 μg/ml trypsin or without trypsin in the medium
IRF-3 and p50 subunits using the Trans-Am ELISA kit. The results are expres
mutated oligonucleotides minus that measured in the presence of the wild
and are compared to non-infected control.Discussion
In these studies we compared the effects of different
LPAIV on transcription factor activation and immune
response gene expression in primary CEH. For the first
time we demonstrate that chicken cells increase activa-
tion of c-Jun, IRF-3 and p50 transcription factors after
AIV infection, which correlated with increased cytokine
expression. Transcription factor activation and immune
response gene induction also correlated with virus
growth.
Early after infection, viruses are capable of triggering a
series of intracellular events which may be accompanied
by changes in host gene expression and activation of a
variety of intracellular signaling pathways that are in part
exploited by the virus to ensure efficient replication [31].
In mammals, influenza virus infection and replication re-
sult in the production of multiple proinflammatory,
chemotactic and antiviral cytokines [32,33]. Cytokine











































































ells were infected for different time periods with LPAIVs at MOI of 1
. Cell lysates (10μg/ml) were tested for binding of the activated c-Jun,
sed as specific binding (absorbance measured in the presence of the
-type oligonucleotides) according to the manufacturer’s instructions
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[34], STAT [35] and IRF [36], in influenza virus infected
cells. However, our understanding of which transcription
factors are involved in the cytokine gene expression
mounted by the chicken cells to AIV is unknown.
When CEHs were infected with LPAIVs in the pres-
ence of trypsin, viral titers were increased, especially the
H7N2 virus. This result suggests that LPAIV cannot rep-
licate very well in CEH without exogenous trypsin. This
is consistent with previous reports that report a need for
trypsin-like proteases to cleave the hemagglutinin pro-
tein into the HA1 and HA2 subunits, which is required
for the virus to be infectious [37,38].
Infection with HPAI in birds and mammals is associ-
ated with severe pathology and increased mortality. One
possible hypothesis for the cause of death in mammals
due to HPAI infection is the acute induction of high
levels of inflammatory cytokines, a so called cytokine
storm [39-41]. The results of our study also demonstrate
increased expression of pro-inflammation cytokines, IL-
6, IL-1β and IFN-α, following LPAIV infection in vitro.
These results correlate with previous studies which have
also demonstrated increased pro-inflammatory cytokines
expression following LPAIV infection [42,43].
Interferon regulatory factors are a family of DNA-
binding proteins involved in mediating the cellular im-
mune response following viral infection. In mammals
influenza virus infection induces activation of IRF-3 sig-
naling [44-46], however its role in chicken immunity re-
mains in question. It has been reported that chicken IRF-3
is activated by type I and type II IFN and its binding
specificity has been demonstrated [47,48]. More recently,
Liniger reported that chicken IRF-3 was required for
virus-mediated type I IFN induction in DF-1 cells [49]. In
our study, we also demonstrate increased IRF-3 produc-
tion after infection with all isolates of LPAIV tested.
The transcription factor NF-κβ is known as a major
regulator of the inflammatory response [50,51]; however,
its role in avian influenza virus replication and virus-
induced immune response is ill-defined. In recent stud-
ies, NF-κB subunit p50 knockout cells demonstrated that
activation of p50 is obsolete for production of interferon
stimulated genes (ISG) upon virus infection [52] and
that p50 is the predominant negative regulator of ISGs
in the context of influenza virus infection [53]. In our
studies, we observed that infection with LPAIV induced
an increase in p50 DNA binding after infection. Further-
more, the increased activation of p50 correlated with a
resulting increase of proinflammatory cytokines. A pre-
vious study has reported that treatment of chicken het-
erophils with either flagellin or lipopolysaccharide
induced a significant increase in DNA binding by the
NF-κB family member p50 [54]. These results demon-
strate the significant role of p50 activation in inducingthe expression of pro-inflammatory cytokines in chicken
following infection.
In mammals, influenza virus infection induces transcrip-
tion factor c-Jun and AP-1 activation and signaling, and
helps to generate many of the biological effects of IFN pro-
duction [34,44-46,55-59]. However in gallinaceous birds very
little was known about the signaling pathways after infection
with AIV. We observed an increase in c-Jun activation after
infection of CEH with LPAIV. The increased transcription
factor activation correlated with increased proinflammatory
response, these sequential processes suggest that c-Jun and
IRF-3 likely mediate the induction of IL-6, IL-1β and IFN-α
gene expression. Similar timing of transcription factor acti-
vation and cytokine gene expression was found in mamma-
lian cells [34,45]. To our knowledge these findings confirm
for the first time, that similar to mammal cells, infection of
chicken cells with LPAIV increases protein expression of
host DNA-binding transcription factors.
Conclusion
Our results demonstrate CEH can efficiently support
growth of the LPAIV with trypsin supplementation in
the medium after infection, especially the H7N2 virus.
After infection all immune response genes tested were
upregulated and the transcription factors, c-Jun, IRF-3
and p50, were also increased compared to sham-infected
controls. These data will broaden our understanding the
avian immune response to infection with LPAIV and has
implications for strategies that target the innate immune
system for improving resistance to avian influenza.
Materials and methods
Cells isolation and culture
Primary CEHs were isolated from 14-day-old white leg-
horn chicken embryos of Specific Pathogen Free (SPF)
eggs as previously described [60] and were cultured at
37°C and 5% CO2 in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum
(Invitrogen, CA,USA), 2 mM glutamine and antibiotics
(final concentration: penicillin, 100 U/ml; streptomycin,
100 μg/ml). Cell viability was assessed by the Trypan Blue
exclusion test and was not less than 90% for each prepar-
ation. Contamination by non-hepatocyte cells was min-
imal by microscopic examination. The cells were counted
and suspensions were diluted to 2 × 106 viable (dye-ex-
cluding) cells per ml. The cells were distributed into 60 ×
15 mm culture dishes (Becton Dickinson, NJ, USA) for
virus growth kinetics and RNA extraction or nuclear ex-
traction, respectively. For each experiment, cells were pre-
pared on the same day and under the same conditions.
Virus and cell culture infection
A/turkey/Wisconsin/68 (H5N9), A/chicken/Texas/167280-
4/02 (H5N3), A/turkey/Virginia/158512/02 (H7N2) and A/
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gated in allantoic cavities of 9–11 day of embryonation SPF
chicken eggs. Viral titers were determined as previously de-
scribed [61]. All experiments using infectious virus were
conducted in bio-safety level 2 (BSL-2) facilities at the
Southeast Poultry Research Laboratory (SEPRL), Agricul-
tural Research Service, United States Department of Agri-
culture (USDA).
Virus growth curves
The growth curves of the viruses were determined by
virus titration of cell culture supernatants at different
time points after infection of primary CEH. Briefly, cells
were infected with each virus at a multiplicity of infec-
tion (MOI) of one in DMEM, negative control cells were
set up identically but without the addition of virus. Cul-
ture dishes were gently rocked every 15 min for 1 h at
37°C, non-adsorbed viruses were removed and the cells
were washed with sterile phosphate buffered saline
(PBS). DMEM supplemented with 2% FBS or 1 μg/mL
TPCK trypsin (Sigma–Aldrich, St. Louis, MO) for CEHs
were added per dish and the dishes were incubated at
37°C and 5% CO2. At 6, 12, 24, and 48 hours post-
infection (hpi), supernatants were collected and stored
at −80°C until used for titrations in SPF embryos. Virus
titers were determined using the method of Reed and
Muench and expressed as 50% egg infectious dose
(EID50) [62].
Isolation of RNA and quantification of cytokine gene
expression
Total RNA was isolated from infected and control cells
at each time point using the RNeasy mini kit (Qiagen) in
accordance with the manufacturer’s instructions, and
treated with RNase-free DNase I (Invitrogen) to remove
genomic DNA. All RNA samples were checked by using
a Nanodrop spectrophotometer (Nanodrop Technolo-
gies, Wilmington, DE). Relative cytokine mRNA expres-
sion in the abovementioned cells were examined by
quantitative RT-PCR. Interleukin (IL)-1β, IL-6, IFN-α,
and Mx expression were determined as previously de-
scribed [15,63]. Briefly, quantitative PCR was performed
for each sample in triplicate in a total volume of 25 μl,
consisting of 12.5 μl iQ SYBR Green supermix (Bio-Rad
Laboratories, CA, USA) with 1 μl of each primer at con-
centration of 10 pmol/μl, 0.5 μl iScript reverse tran-
scriptase, 5 μl RNase/DNase-free water, and 5 μl diluted
RNA. PCR conditions were the same for each targeted
gene and are as follows: 10 min at 50°C, 95°C for 5 min,
followed by 45 cycles of 95°C for 10 s and 58°C for 30 s.
For each reaction, melting curves were analyzed to deter-
mine the specificity of each gene. Primers were derived
from previously published sequence and synthesized by
Integrated DNA Technologies [64]. Sequences are asfollows (forward, reverse): IL-6 (5’-GCGAGAACAG
CATGGAGATG-3’, 5’-CTGTTCGCCTTTCAGACCTAC-
3’); IL-1β (5’-ACATGTCGTGTGTGATGA-3’, 5’-GCTT
CATCTTCTACCGCCTG-3’); IFN-α (5’-GACAGCCA
ACGCCAAAGC-3’, 5’-AATGCTTGAGCAGCAGCGA
C-3’); Mx (5’-CAGGACATCAACGACAATCT-3’, 5’-
TTGCCAGATGAGGGATAGTA-3’) and 28S (5’-GGC
GAAGCCAGAGGAAACT-3’, 5’-GACGACCGATTTGCA
CGTC-3’). RNA from individual cell samples was normal-
ized using 28S house-keeping gene. For each gene, ampli-
fication was verified using four 10-fold serial dilutions of
standard spleen cell RNA in the same PCR run. Expres-
sion was determined by the standard curve method [65].
Data are expressed as fold change in cytokine messenger
RNA (mRNA) levels in infected groups compared with
those from uninfected groups.
c-Jun, IRF-3 and p50 activation analysis
The ELISA-based Trans-Am transcription factor kits
(Active Motif, Carlsbad, CA, USA) were used to detect
and quantify c-Jun, IRF-3 and p50 activation as previ-
ously described [54]. The 96-well plates are contain
immobilized oligonucleotides containing transcription
response elements for c-Jun (5′-TGAGTCA-3′), NF-κβ
p50 consensus binding site (5′-GGGACTTTCC-3′) or
IRF consensus binding site (5′-GAAACTGAAACT-3′).
The active forms of the subunits for c-Jun or p50 or
IRF-3 in nuclear extracts can be detected using specific
antibodies for epitopes that are accessible only when the
nuclear factors are activated and bound to their target
DNA. Preparation of nuclear extract was done according
to the manufacturer’s instructions. The specificity of the
assays was checked by measuring the ability of soluble
wild type or mutated c-Jun, p50 and IRF-3 oligonucleo-
tides to inhibit binding. The results are expressed as spe-
cific binding (absorbance measured in the presence of
the mutated oligonucleotides minus that measured in
the presence of the wild-type oligonucleotides) according
to the manufacturer’s instructions.
Statistical analyses
Data are expressed as the mean ± standard deviation.
Statistical differences were analyzed with Tukey one-way
ANOVA using Prism 5 (GraphPad Co., San Diego, CA).
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